The value of comparative ultrasound and novel biomarkers in the diagnosis and treatment of acute kidney injury in sepsis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025735

Enrollment

Unknown

Registered

2019-09-07

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic acute kidney injury

Interventions

Gold Standard:Ultrasound diagnosis

clinical outcome

Index test:novel biomarkers

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: All ICU patients with sepsis and sepsis AKI, aged 18 to 80 years, and survival time >48 h.

Exclusion criteria

Exclusion criteria: Pregnant women, patients who gave up treatment during hospitalization, renal insufficiency caused by urinary tract obstruction, long-term dialysis treatment for patients with chronic renal failure, AKI recovery period and recent use of contrast agents, and those with obvious abdominal distension were not included in the study.

Design outcomes

Primary

Measure	Time frame
RI;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactLixia Liu

The Fourth Hospital of Hebei Medical University

icudoczk@163.com+86 13833186570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026